The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Involvement of endogenous tumor necrosis factor alpha and transforming growth factor beta during induction of collagen type II arthritis in mice.
Open accessAbstract
Both tumor necrosis factor alpha (TNF-alpha) and transforming growth factor beta (TGF-beta) are found in synovial fluid from arthritic joints of humans and of rodents with experimental arthritis. The role of endogenously produced TGF-beta and TNF in the pathogenesis of collagen type II-induced arthritis (CIA) in DBA/1 mice was examined by determining the effect of neutralizing monoclonal antibodies to these factors on the course of the disease. Endogenously produced as well as systemically administered TGF-beta 1 and TNF-alpha had opposite effects, since TGF-beta 1 and anti-TNF protected against CIA, whereas anti-TGF-beta and TNF-alpha increased CIA incidence and/or severity. Intraperitoneally injected TGF-beta 1 at a dose of 2 micrograms per day for 14 days significantly ameliorated arthritis, even when started at the time of arthritis development, although it did not reverse established disease. The resistance to CIA induction caused by a prior intravenous injection of collagen type II was not significantly influenced by the simultaneous injection of TGF-beta 1, TNF-alpha, or interleukin 1 alpha. It is concluded that the endogenous production of TNF and TGF-beta is important in determining the course of CIA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Derynck, R., Jarrett, J. A., Chen, E. Y., Eaton, D. H., Bell, J. R., Assoian, R. K., Roberts, A. B., Sporn, M. B., & Goeddel, D. V. (1985) · Nature · doi:10.1038/316701a0 · Cited by 1,667
Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis.
Keffer, J., Probert, L., Cazlaris, H., Georgopoulos, S., Kaslaris, E., Kioussis, D., & Kollias, G. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04978.x · Cited by 1,660
Autoimmunity to type II collagen an experimental model of arthritis.
Trentham, D. E., Townes, A. S., & Kang, A. H. (1977) · The Journal of experimental medicine · doi:10.1084/jem.146.3.857 · Cited by 1,603
Kehrl, J. H., Wakefield, L. M., Roberts, A. B., Jakowlew, S., Alvarez-Mon, M., Derynck, R., Sporn, M. B., & Fauci, A. S. (1986) · The Journal of experimental medicine · doi:10.1084/jem.163.5.1037 · Cited by 1,582
Transforming Growth Factor-β: Biological Function and Chemical Structure
Sporn, M. B., Roberts, A. B., Wakefield, L. M., & Assoian, R. K. (1986) · Science · doi:10.1126/science.3487831 · Cited by 1,182
Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes.
Kehrl, J. H., Roberts, A. B., Wakefield, L. M., Jakowlew, S., Sporn, M. B., & Fauci, A. S. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.12.3855 · Cited by 759
Ruddle, N. H., Bergman, C. M., McGrath, K. M., Lingenheld, E. G., Grunnet, M. L., Padula, S. J., & Clark, R. B. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.4.1193 · Cited by 688
Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist.
Arend, W. P., Welgus, H. G., Thompson, R. C., & Eisenberg, S. P. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114622 · Cited by 581
Rook, A. H., Kehrl, J. H., Wakefield, L. M., Roberts, A. B., Sporn, M. B., Burlington, D. B., Lane, H. C., & Fauci, A. S. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.10.3916 · Cited by 570
Ding, A., Nathan, C. F., Graycar, J., Derynck, R., Stuehr, D. J., & Srimal, S. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.3.940 · Cited by 500
Ranges, G. E., Figari, I. S., Espevik, T., & Palladino, M. A. (1987) · The Journal of experimental medicine · doi:10.1084/jem.166.4.991 · Cited by 494
Self-citationInhibition of cytokine production by cyclosporin A and transforming growth factor beta.
Espevik, T., Figari, I. S., Shalaby, M. R., Lackides, G. A., Lewis, G. D., Shepard, H. M., & Palladino, M. A. (1987) · The Journal of experimental medicine · doi:10.1084/jem.166.2.571 · Cited by 447
Self-citationAnti—tumor necrosis factor therapy abrogates autoimmune demyelination
Selmaj, K., Raine, C. S., & Cross, A. H. (1991) · Annals of Neurology · doi:10.1002/ana.410300510 · Cited by 436
Protective effect of transforming growth factor beta 1 on experimental autoimmune diseases in mice.
Kuruvilla, A. P., Shah, R., Hochwald, G. M., Liggitt, H. D., Palladino, M. A., & Thorbecke, G. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.7.2918 · Cited by 399
Self-citationCloning and expression in Escherichia coli of the cDNA for murine tumor necrosis factor.
Pennica, D., Hayflick, J. S., Bringman, T. S., Palladino, M. A., & Goeddel, D. V. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.18.6060 · Cited by 390
Self-citationSheehan, K. C. F., Ruddle, N. H., & Schreiber, R. D. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.11.3884 · Cited by 379
Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4.
Ranges, G. E., Sriram, S., & Cooper, S. M. (1985) · The Journal of experimental medicine · doi:10.1084/jem.162.3.1105 · Cited by 365
Nagler-Anderson, C., Bober, L. A., Robinson, M. E., Siskind, G. W., & Thorbecke, G. J. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.19.7443 · Cited by 351
Self-citationModulation of cytokine production by transforming growth factor-beta.
Chantry, D., Turner, M., Abney, E., & Feldmann, M. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.12.4295 · Cited by 323
Czarniecki, C. W., Chiu, H. H., Wong, G. H. W., McCabe, S. M., & Palladino, M. A. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.12.4217 · Cited by 294
Self-citationHavell, E. A., Fiers, W., & North, R. J. (1988) · The Journal of experimental medicine · doi:10.1084/jem.167.3.1067 · Cited by 276
Rapid onset synovial inflammation and hyperplasia induced by transforming growth factor beta.
Allen, J. B., Manthey, C. L., Hand, A. R., Ohura, K., Ellingsworth, L., & Wahl, S. M. (1990) · The Journal of experimental medicine · doi:10.1084/jem.171.1.231 · Cited by 258
Dubois, C. M., Ruscetti, F. W., Palaszynski, E. W., Falk, L. A., Oppenheim, J. J., & Keller, J. R. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.3.737 · Cited by 225
Karpus, W. J., & Swanborg, R. H. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.4.1163 · Cited by 172
Espevik, T., Figari, I. S., Ranges, G. E., & Palladino, M. A. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.7.2312 · Cited by 168
Self-citationLucas, C., Bald, L. N., Fendly, B. M., Mora-Worms, M., Figari, I. S., Patzer, E. J., & Palladino, M. A. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.5.1415 · Cited by 164
Self-citationInduction of the interleukin 1 receptor antagonist protein by transforming growth factor‐β
Turner, M., Chantry, D., Katsikis, P., Berge, A., Brennan, F. M., & Feldmann, M. (1991) · European Journal of Immunology · doi:10.1002/eji.1830210708 · Cited by 163
In vivo administration with IL-1 accelerates the development of collagen-induced arthritis in mice.
Hom, J. T., Bendele, A. M., & Carlson, D. G. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.3.834 · Cited by 153
Zvaifler, N. J., Steinman, R. M., Kaplan, G., Lau, L. L., & Rivelis, M. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112036 · Cited by 132
Zuber, P., Kuppner, M. C., & de Tribolet, N. (1988) · European Journal of Immunology · doi:10.1002/eji.1830181023 · Cited by 110
Hiraki, Y., Inoue, H., Hirai, R., Kato, Y., & Suzuki, F. (1988) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(88)90092-4 · Cited by 96
Cooper, S. M., Sriram, S., & Ranges, G. E. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.6.1958 · Cited by 91
Ristow, H. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.15.5531 · Cited by 91
Suppression of immune cell function in vitro by recombinant human transforming growth factor-β
Shalaby, M. R., & Ammann, A. J. (1988) · Cellular Immunology · doi:10.1016/0008-8749(88)90303-6 · Cited by 49
Belsito, D. V., Epstein, S., Schultz, J. M., Baer, R. L., & Thorbecke, G. J. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.5.1530 · Cited by 46
Self-citationEffects of cyclosporin on collagen induced arthritis in mice.
Takagishi, K., Kaibara, N., Hotokebuchi, T., Arita, C., Morinaga, M., & Arai, K. (1986) · Annals of the Rheumatic Diseases · doi:10.1136/ard.45.4.339 · Cited by 45
Cited by
ROLE OF CYTOKINES IN RHEUMATOID ARTHRITIS
Feldmann, M., Brennan, F. M., & Maini, R. N. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.397 · Cited by 2,514
TRANSFORMING GROWTH FACTOR-β REGULATION OF IMMUNE RESPONSES
Li, M. O., Wan, Y. Y., Sanjabi, S., Robertson, A.-K. L., & Flavell, R. A. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090737 · Cited by 2,206
TNF-mediated inflammatory disease
Bradley, Jr. (2008) · The Journal of Pathology · doi:10.1002/path.2287 · Cited by 2,094
REGULATION OF IMMUNE RESPONSES BY TGF-β
Letterio, J. J., & Roberts, A. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.137 · Cited by 1,890
Elliott, M. J., Maini, R. N., Feldmann, M., Kalden, J. R., Antoni, C., Smolen, J. S., Leeb, B., Breedveld, F. C., Macfarlane, J. D., Bijl, J. A., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90628-9 · Cited by 1,682
Metadata
- Authors
- Thorbecke, G. J., Shah, R., Leu, C. H., Kuruvilla, A. P., Hardison, A. M., & Palladino, M. A.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1992-08-15
- Volume
- 89
- Issue
- 16
- Pages
- 7375-7379
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2133602875
- Cited by
- 360
- References
- 36
- FWCI
- 12.85
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.